PEG-IFNalpha/RBV combination therapy for chronic hepatitis C patients increases serum ferritin level while it improves sustained viral response rate (Q43196114)
Jump to navigation
Jump to search
scientific article published on 5 January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PEG-IFNalpha/RBV combination therapy for chronic hepatitis C patients increases serum ferritin level while it improves sustained viral response rate |
scientific article published on 5 January 2010 |
Statements
1 reference
PEG-IFNalpha/RBV combination therapy for chronic hepatitis C patients increases serum ferritin level while it improves sustained viral response rate (English)
1 reference
1 reference
Norihisa Yada
1 reference
Hobyung Chung
1 reference
Sosuke Hayaishi
1 reference
Masahiro Takita
1 reference
Taisuke Ueda
1 reference
Chie Tatsumi
1 reference
Kinuyo Hatanaka
1 reference
Satoshi Kitai
1 reference
Emi Ishikawa
1 reference
Tatsuo Inoue
1 reference
Satoru Hagiwara
1 reference
Kazuomi Ueshima
1 reference
5 January 2010
1 reference
1 reference
53
1 reference
1
1 reference
60-65
1 reference
Identifiers
1 reference
1 reference